Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Helixon Biotechnology (Suzhou) Co., Ltd.
Real, source-linked trial activity for Helixon Biotechnology (Suzhou) Co., Ltd: 2 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Oct 29, 2026. Source-linked, daily-refreshed.
PHASE1 2
Newest Helixon Biotechnology (Suzhou) Co., Ltd trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | Study of HXN-1013 in Healthy Participants and Participants With Mild-t | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 56d ago | A Phase I Study of HXN5003 in Healthy Participants and Patients With M | Ph 1 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Helixon Biotechnology (Suzhou) Co., Ltd (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.